HTG Molecular Diagnostics Inc (HTGMQ)
0.0025
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
HTG Molecular Diagnostics Cash from Investing (TTM): 3.484M for March 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2023 | 3.484M |
| December 31, 2022 | 12.42M |
| September 30, 2022 | 11.92M |
| June 30, 2022 | 7.428M |
| March 31, 2022 | 1.512M |
| December 31, 2021 | -6.665M |
| September 30, 2021 | -4.196M |
| June 30, 2021 | -4.739M |
| March 31, 2021 | 11.99M |
| December 31, 2020 | 18.73M |
| September 30, 2020 | -9.163M |
| June 30, 2020 | -2.939M |
| March 31, 2020 | -4.149M |
| December 31, 2019 | -3.504M |
| September 30, 2019 | 24.09M |
| June 30, 2019 | 25.18M |
| March 31, 2019 | 6.905M |
| Date | Value |
|---|---|
| December 31, 2018 | -23.22M |
| September 30, 2018 | -28.68M |
| June 30, 2018 | -36.48M |
| March 31, 2018 | -23.88M |
| December 31, 2017 | 3.280M |
| September 30, 2017 | 10.44M |
| June 30, 2017 | 14.87M |
| March 31, 2017 | 23.28M |
| December 31, 2016 | 24.42M |
| September 30, 2016 | 23.00M |
| June 30, 2016 | 14.84M |
| March 31, 2016 | -29.06M |
| December 31, 2015 | -32.18M |
| September 30, 2015 | -37.68M |
| June 30, 2015 | -33.81M |
| March 31, 2015 | -1.074M |
| December 31, 2014 | -0.8577M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-9.163M
Minimum
Sep 2020
25.18M
Maximum
Jun 2019
5.088M
Average
2.498M
Median
Cash from Investing (TTM) Benchmarks
| Viveve Medical Inc | -0.595M |
| Minerva Surgical Inc | -0.053M |
| Stereotaxis Inc | 19.76M |
| Electromed Inc | -1.219M |
| Myomo Inc | -2.030M |